A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
The purpose of this multi-center event-driven study in non-dialysis (ND) participants with anemia associated with chronic kidney disease (CKD) is to evaluate the safety and efficacy of daprodustat compared to darbepoetin alfa.
Inclusion Criteria:
Exclusion Criteria:
Jämejala Village, 71024, Estonia
Heraklion-Crete, 71110, Greece
Ciudad de Mexico, State of Mexico 14080, Mexico
Zapopan, Jalisco, 45030, Mexico
Takapuna, Auckland, ?0740, New Zealand
Baguio City, Benguet, 2600, Philippines
Sto Tomas, 4234, Philippines
Mytischi, 141009, Russia
Anyang-Si, Gyeonggi-do, 14068, South Korea
Taoyuan Hsien, 333, Taiwan
Bangkoknoi, 10700, Thailand
Fife, KY2 5AH, United Kingdom